Thyroid function and serum electrolytes: does an association really exist?

BACKGROUND Thyroid hormone is a central regulator of body functions. Disorders of thyroid function are considered to be a cause of electrolyte disorders. Only few data on the association between thyroid function and electrolyte disorders exists. METHODS In the present retrospective analysis data from all patients admitted to the Department of Emergency Medicine of a university hospital who had measurements of thyroid function (TSH, fT(3), fT(4)) and electrolytes were included. RESULTS 9,012 patients with measurement of TSH and electrolytes were available. 86% of patients had normal, 4% suppressed and 10% elevated TSH. Serum sodium was significantly lower in patients with high TSH levels (p <0.01). There was a significant correlation between serum TSH and phosphate level (p <0.05). Phosphate levels were higher in patients with elevated TSH than in patients with normal TSH (p <0.01). Serum calcium and magnesium correlated significantly with TSH (p <0.05). fT(3) levels correlated significantly with calcium (p <0.05). Hyponatraemia was present in 14% of patients with high TSH and was significantly more common than in the group with normal TSH levels of which 9% had hyponatraemia (p <0.01). Hypokalaemia was more common in the group with elevated TSH than in those with normal TSH (14 versus 11%, p = 0.016). Hyperkalaemia was more common in the group with high TSH levels (7%) than in those with normal TSH (7 vs. 4%, p <0.01). CONCLUSION An association between thyroid function and electrolyte disorders seems to exist, although it is probably only relevant in marked hypo-/hyperthyroidism.

[1]  H. Chen,et al.  Hypokalemia Is Associated with Increased Mortality Rate in Chronic Hemodialysis Patients , 2011, Blood Purification.

[2]  T. Benzing,et al.  [Practical approach to hyponatremia]. , 2011, Deutsche medizinische Wochenschrift.

[3]  陶仲为,et al.  Hyponatremia , 2010 .

[4]  Marcus J Schultz,et al.  Treatment of hypophosphatemia in the intensive care unit: a review , 2010, Critical care.

[5]  B. Souweine,et al.  Association between hypernatraemia acquired in the ICU and mortality: a cohort study. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  G. Funk,et al.  Intensive care-acquired hypernatremia after major cardiothoracic surgery is associated with increased mortality , 2010, Intensive Care Medicine.

[7]  M. Molloy,et al.  Hyponatremia independent of osteoporosis is associated with fracture occurrence. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[8]  P. Metnitz,et al.  Incidence and prognosis of dysnatremias present on ICU admission , 2010, Intensive Care Medicine.

[9]  Alexandra Kaider,et al.  Hypernatremia in the critically ill is an independent risk factor for mortality. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  T. Shigematsu,et al.  Fibroblast growth factor-23 in patients with Graves' disease before and after antithyroid therapy: its important role in serum phosphate regulation. , 2005, The Journal of clinical endocrinology and metabolism.

[11]  Arthur Greenberg,et al.  Primer on Kidney Diseases , 2005 .

[12]  D. Gallina,et al.  Hypercalcemia in hyperthyroidism: patterns of serum calcium, parathyroid hormone, and 1,25-dihydroxyvitamin D3 levels during management of thyrotoxicosis. , 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[13]  D. Ellison,et al.  Renal expression of sodium transporters and aquaporin-2 in hypothyroid rats. , 2003, American journal of physiology. Renal physiology.

[14]  H. M. Soliman,et al.  Development of ionized hypomagnesemia is associated with higher mortality rates , 2003, Critical care medicine.

[15]  R. Prasad,et al.  Molecular basis of renal handling of calcium in response to thyroid hormone status of rat. , 2002, Biochimica et biophysica acta.

[16]  C. Park,et al.  Thyroxine treatment induces upregulation of renin-angiotensin-aldosterone system due to decreasing effective plasma volume in patients with primary myxoedema. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  M. Levi,et al.  Role of Thyroid Hormone in Regulation of Renal Phosphate Transport in Young and Aged Rats. , 1999, Endocrinology.

[18]  L. Crapo,et al.  Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. , 1999, Archives of internal medicine.

[19]  Mitchell L. Halperin,et al.  Fluid, Electrolyte and Acid-Base Physiology: A Problem-Based Approach , 1998 .

[20]  D. O’Reilly,et al.  Absence of relation between hyponatraemia and hypothyroidism , 1997, The Lancet.

[21]  M. Scanlon,et al.  Hyponatraemia, hypothyroidism, and role of arginine-vasopressin , 1997, The Lancet.

[22]  Y. Oiso,et al.  Osmoregulation of plasma vasopressin in myxedema. , 1990, The Journal of clinical endocrinology and metabolism.

[23]  H. Wuttke,et al.  [Clinical significance of serum magnesium concentration in thyrotoxicosis (author's transl)]. , 1976, Medizinische Klinik.

[24]  B. M. Dobyns,et al.  HYPERCALCAEMIA AND THYROTOXICOSIS , 1974, The Medical journal of Australia.

[25]  L. Mariani,et al.  The renal manifestations of thyroid disease. , 2012, Journal of the American Society of Nephrology : JASN.

[26]  M. Manto,et al.  Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. , 2006, The American journal of medicine.

[27]  Burton David. Rose,et al.  Clinical Physiology of Acid-Base and Electrolyte Disorders , 1977 .